TY - JOUR
T1 - PET/MR Imaging of the Pancreas
AU - Mallak, Nadine
AU - Hope, Thomas A.
AU - Guimaraes, Alexander R.
N1 - Funding Information:
Disclosure: Dr T.A. Hope has received grant support from GE Healthcare ; Dr A.R. Guimaraes is affiliated with Siemens Speaker’s Bureau, AGFA Imaging, Merck Pharmaceuticals, Inc; Dr N. Mallak has nothing to disclose.
Publisher Copyright:
© 2018 Elsevier Inc.
Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2018/8
Y1 - 2018/8
N2 - PET/MR imaging has the potential to markedly alter pancreatic care in both the malignant, and premalignant states with the ability to perform robust, high-resolution, quantitative molecular imaging. The ability of PET/MR imaging to monitor disease processes, potentially correct for motion in the upper abdomen, and provide novel biomarkers that may be a combination of MR imaging and PET biomarkers, offers a unique, precise interrogation of the pancreatic milieu going forward.
AB - PET/MR imaging has the potential to markedly alter pancreatic care in both the malignant, and premalignant states with the ability to perform robust, high-resolution, quantitative molecular imaging. The ability of PET/MR imaging to monitor disease processes, potentially correct for motion in the upper abdomen, and provide novel biomarkers that may be a combination of MR imaging and PET biomarkers, offers a unique, precise interrogation of the pancreatic milieu going forward.
KW - DOTATATE
KW - Neuroendocrine tumor
KW - PET/MR imaging
KW - Pancreas
UR - http://www.scopus.com/inward/record.url?scp=85049327121&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85049327121&partnerID=8YFLogxK
U2 - 10.1016/j.mric.2018.03.003
DO - 10.1016/j.mric.2018.03.003
M3 - Review article
C2 - 30376974
AN - SCOPUS:85049327121
VL - 26
SP - 345
EP - 362
JO - Magnetic Resonance Imaging Clinics of North America
JF - Magnetic Resonance Imaging Clinics of North America
SN - 1064-9689
IS - 3
ER -